Healthcare Industry News: osteoporosis
News Release - June 10, 2008
Orthofix International Appoints Chief Compliance and Government Affairs OfficerBOSTON--(HSMN NewsFeed)--Orthofix International N.V. (NASDAQ: OFIX ) announced today that Denise Pedulla has been appointed to the position of Senior Vice President and Chief Compliance Officer effective as of June 9, 2008.
Ms. Pedulla was formerly Vice President, Compliance, Regulatory and Government Affairs and Associate General Counsel for Fresenius Medical Care North America. She will be responsible for managing Orthofix’s domestic and international corporate compliance and government affairs programs. An attorney, Ms. Pedulla has more than 14 years of experience in health care regulatory compliance, having worked in-house and in private practice with for-profit and not-for-profit health care businesses in the areas of health care regulation and compliance program development and implementation. Ms. Pedulla will report to Orthofix’s CEO and will also have independent reporting obligations to the Audit Committee and the full Board of Directors.
“We are committed to the implementation of best practices related to corporate governance, and to the development of a culture of transparency and accountability in all areas of the company,” said Orthofix’s CEO Alan Milinazzo. “With her extensive background in health care regulatory compliance, we believe that Denise’s leadership of our Integrity Advantage program will enhance our ability to maintain a comprehensive corporate compliance program for our company and our shareholders.”
Ms. Pedulla, 48, holds a Bachelor of Science degree in Nursing and Psychology from Boston College, a Masters of Public Health degree in Health Policy and Management from Harvard University, and a Juris Doctorate degree from Suffolk University in Boston, Massachusetts. Ms. Pedulla is also certified in health care compliance by the Health Care Compliance Association.
Orthofix International, N.V., a global diversified orthopedic products company, offers a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages–helping them achieve a more active and mobile lifestyle. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, including BREG, Inc. and Blackstone Medical, Inc., and via partnerships with other leading orthopedic product companies. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Orthopedic Research and Education Foundation, Rutgers University, the Cleveland Clinic Foundation, Texas Scottish Rite Hospital for Children and National osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.
Source: Orthofix International
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.